Tuberculosis - An epidemic of injustice

Journal of the Royal College of Physicians of London

Volumn 31, Issue 6, 1997, Pages 637-639

  Grange, John ^a   Zumla, Alimuddin ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; SHORT SURVEY; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DISEASE OUTBREAKS; HIV INFECTIONS; HUMANS; PREVALENCE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 0031431168     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. World Health Organization Global Tuberculosis programme. World Tuberculosis Day. Geneva: World Health Organization, 1997 (WHO/TB/97.222).
2. World Health Organization. TB - A global emergency. Geneva: World Health Organization, 1994 (WHO/TB/94.177).
3. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organisation. Tubercle 1991;72:1-6.
4. Zumla A, Chintu C. Childhood tuberculosis and infection with the human immunodeficiency virus. J R Coll Physicians Lond 1995;29:92-5.
5. Floyd K, Wilkinson D, Gilks CF. Health system costs. In: Floyd K, Wilkinson D, Gilles CF (eds) Community-based, directly observed therapy for tuberculosis: An economic analysis. Tygerberg, South Africa: Medical Research Council, 1997;50-63.
6. Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24.
7. World Health Organization. The HIV/AIDS and tuberculosis epidemics. Implications for TB control. Geneva: World Health Organization, 1994 (WHO/TB/CARG(4)/94.4).
8. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull Wld Hlth Org 1994;72:213-20.
9. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organization, 1994 (WHO/TB/94.178).
10. Rieder HL. Drug-resistant tuberculosis: issues in epidemiology and challenges for public health. Tubercle Lung Dis 1994;75:321-3.
11. Scott GM, Darbyshire JH. Management of mycobacterial infections. In: Zumla A, Johnson M, Miller RF (eds) AIDS and Respiratory Medicine. London: Chapman and Hall ITP, 1997: 177-97.
12. Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Publ Hlth Rep 1992;107:626-36.
13. Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patient adherence. Am Rev Respir Dis 1993;147:1311-20.
14. Sbabaro J. Patient compliance with preventive therapy. Operational considerations. Bull Int Union Tuberc Lung Dis 1990;66:37-9.
15. Grange JM, Festenstein F. The human dimension of tuberculosis control. Tubercle Lung Dis 1993;74:219-22.
16. World Health Organization. WHO model prescribing information. Drugs used in mycobacterial diseases. Geneva: World Health Organization, 1991.
17. Raviglione MC, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. Lancet 1997;350:624-9.
18. Grange J, Zumla A. Making DOTS succeed. Lancet 1997;350:157.
19. Uplekar MW, Shepard DS. Treatment of tuberculosis by private practitioners in India. Tubercle 1991;72:284-90.